Literature DB >> 11097960

Familial aggregation of psychotic symptoms in Huntington's disease.

D Tsuang1, E W Almqvist, H Lipe, F Strgar, L DiGiacomo, D Hoff, C Eugenio, M R Hayden, T D Bird.   

Abstract

OBJECTIVE: The mutation responsible for Huntington's disease is an elongated and unstable trinucleotide (CAG) repeat on the short arm of chromosome 4. Psychotic symptoms are more common in patients with Huntington's disease than in the general population. This study explored the relationship of psychosis in Huntington's disease patients with the number of CAG repeats and family history of psychosis.
METHOD: Forty-four patients with Huntington's disease, 22 with and 22 without psychotic symptoms, were recruited from two university-affiliated medical genetics clinics in Seattle and Vancouver, B.C. Psychiatric assessments of the subjects were made through chart review, and diagnoses were validated by structured interviews in a subset of patients. The demographic and clinical characteristics of the psychotic and nonpsychotic patients were compared.
RESULTS: The two groups did not differ in demographic and clinical characteristics, except that subjects with psychosis were significantly more likely than nonpsychotic subjects to have a first-degree relative with psychosis. In eight of nine families in which Huntington's disease probands with psychosis had a first-degree relative with psychosis, the relative's psychosis co-occurred with Huntington's disease. In the Huntington's disease probands with psychosis, the onset of psychosis correlated with the onset of the neurological symptoms of Huntington's disease, and the age at onset of psychosis was lower in probands with a higher number of CAG repeats.
CONCLUSIONS: Patients with Huntington's disease and psychotic symptoms may have a familial predisposition to develop psychosis. This finding suggests that other genetic factors may influence susceptibility to a particular phenotype precipitated by CAG expansion in the Huntington's disease gene.

Entities:  

Mesh:

Year:  2000        PMID: 11097960     DOI: 10.1176/appi.ajp.157.12.1955

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  12 in total

1.  Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis.

Authors:  Randi-Michelle Cowin; Nghiem Bui; Deanna Graham; Jennie R Green; Lisa A Yuva-Paylor; Andreas Weiss; Richard Paylor
Journal:  Mamm Genome       Date:  2012-06       Impact factor: 2.957

Review 2.  Anticipation and CAG*CTG repeat expansion in schizophrenia and bipolar affective disorder.

Authors:  M Teresa Fortune; James L Kennedy; John B Vincent
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 3.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 4.  Genetics of psychosis in Alzheimer's disease: a review.

Authors:  Mary Ann DeMichele-Sweet; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 5.  Genetic counselling for schizophrenia in the era of molecular genetics.

Authors:  K A Hodgkinson; J Murphy; S O'Neill; L Brzustowicz; A S Bassett
Journal:  Can J Psychiatry       Date:  2001-03       Impact factor: 4.356

Review 6.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

Review 7.  Cerebral correlates of psychotic syndromes in neurodegenerative diseases.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

8.  Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree.

Authors:  Bernardo Barahona Corrêa; Miguel Xavier; João Guimarães
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-02-15

9.  The Spectrum of Psychiatric Pathology in a Patient with Genetically Verified Huntington's Disease.

Authors:  Samir Alkabie; Daljinder Singh; Amy Hernandez; Rhaisa Dumenigo
Journal:  Case Rep Psychiatry       Date:  2015-09-16

10.  The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database.

Authors:  Natalia P Rocha; Benson Mwangi; Carlos A Gutierrez Candano; Cristina Sampaio; Erin Furr Stimming; Antonio L Teixeira
Journal:  Front Neurol       Date:  2018-11-06       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.